018700632

PROSION

---

May 9, 2022

Trademark Summary

The trademark application PROSION was filed by PROSION GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on June 28, 2022, and it was registered by office on October 5, 2022 without any oppositions.

The application was filed in German (English was selected as the second language).

---

Goods And Services

• The mark was filed in class 1 with following description of goods:
  
  1. Amino acids for scientific purposes
  2. Protein [raw material]
  3. Enzymes for scientific purposes
  4. Enzyme substrates for scientific purposes
  5. Peptide substrates for scientific purposes
  6. Chemical preparations for use in the manufacture of pharmaceuticals
  7. Chemical preparations for use in the manufacture of pharmaceuticals
  8. Chemicals for use in the pharmaceutical industry
  9. Chemical preparations for use in the manufacture of pharmaceuticals
  10. Proteins for use in science
  11. Peptides for industrial purposes
  12. Polypeptides for scientific purposes
  13. Biochemicals namely, polypeptides for in vitro research use
  14. Proteins for use in industry.
• The mark was filed in class 5 with following description of goods:
  
  1. Medicine
  2. Pharmaceutical preparations
  3. Pharmaceutical compositions
  4. Amino acids for medical purposes
  5. Amino acid preparations for pharmaceutical use
  6. Protein synthesis inhibitors
  7. Enzymes for medical purposes
  8. Enzyme preparations for medical purposes
  9. Synthetic peptides for pharmaceutical purposes
  10. Chemico-pharmaceutical preparations
  11. Chemical preparations for pharmaceutical purposes
  12. Chemicals for pharmaceutical use
  13. Chemico-pharmaceutical preparations
  14. Pharmaceutical preparations for the treatment of autoimmune diseases
  15. Pharmaceutical preparations for activating cellular function
  16. Pharmaceutical preparations for the treatment of autoimmune disorders
  17. Pharmaceutical preparations for the prevention of diseases of the nervous system
  18. Pharmaceutical preparations for the prevention of disorders of the nervous system
  19. Pharmaceutical preparations for the treatment of cancer
  20. Pharmaceutical preparations for use in oncology
  21. Pharmaceutical preparations and substances for the prevention of cancer
  22. Pharmaceutical preparations for treating diabetes
  23. Pharmaceutical preparations for human use
  24. Pharmaceutical preparations and substances for the treatment of cancer
  25. Pharmaceutical preparations for treating malignant tumors
  26. Pharmaceutical preparations for the prevention of autoimmune diseases
  27. Pharmaceutical preparations for peripheral nervous system
  28. Pharmaceutical preparations and substances for use in oncology
  29. Pharmaceuticals
  30. Pharmaceutical preparations for the prevention of diseases of the immune system.
• The mark was filed in class 42 with following description of goods:
  
  1. Pharmaceutical products development
  2. Development of pharmaceutical preparations and medicines
  3. Providing information about the results of clinical trials for pharmaceutical products
  4. Consultancy relating to research in the field of pharmacogenetics
  5. Pharmaceutical research services
  6. Pharmaceutical research and development
  7. Services for assessing the efficiency of pharmaceuticals
  8. Laboratory research services relating to pharmaceuticals
  9. Pharmaceutical research and development
  10. Consultancy in the field of pharmaceutical research
  11. Research and development for the pharmaceutical industry
  12. Consultancy pertaining to pharmacology
  13. Research and development in the pharmaceutical and biotechnology fields
  14. Medical and pharmacological research services
  15. Conducting clinical trials for pharmaceutical products
  16. Research on the subject of pharmaceuticals
  17. Consultancy relating to pharmaceutical research and development
  18. Pharmaceutical product evaluation
  19. Research on the subject of pharmaceuticals
  20. Pharmaceutical drug development services.